Literature DB >> 31050348

Simultaneous measurement of blood pressure and RBC aggregation by monitoring on-off blood flows supplied from a disposable air-compressed pump.

Yang Jun Kang1.   

Abstract

Haematological diseases significantly increase RBC aggregation. Specifically, RBC aggregation is considerably varied by haematological factors including cellular properties, and suspending medium properties. Thus, in order to ensure consistent measurement of RBC aggregation, it is necessary to measure RBC aggregation and blood pressure simultaneously. Here, a method for simultaneously measuring RBC aggregation and blood pressure is demonstrated by analyzing blood flows supplied from a disposable air-compressed pump. A microfluidic device is composed of two parallel microfluidic channels (i.e., PBS channel and blood channel), an inlet, and outlets. After the PBS channel is filled with the PBS solution, the outlets of the PBS channel are completely closed with two pinch valves. Under varying blood flow rates of the disposable pump, the blood pressure index (PI) is quantified by analyzing the image intensity of RBCs in the PBS channel. Thereafter, at stasis, the RBC aggregation index (AI) is calculated by analyzing the image intensity of blood in the blood channel. First, under a constant blood flow-rate of a syringe pump, the image intensity of RBCs collected in the PBS channel (IPC) is linearly proportional to blood pressure estimated in the blood channel (PBC). Second, with respect to variations in the blood flow-rate of the proposed pump, the IPC and PBC decrease gradually over time. Two blood pressure indices (PI [PBC], and PI [IPC]) are obtained by averaging temporal variations in the PBC and IPC, respectively. The results of the regression analysis indicate that the coefficient of the linear regression yields a higher value of R2 = 0.9051. Subsequently, the PI (IPC) is effectively used to estimate blood pressure. Finally, the variations in blood pressure and RBC aggregation are obtained by using aggregation-enhanced blood samples and deformability-reduced blood samples. Thus, the proposed method leads to consistent variations in the PI and AI, when compared with the previous results. The experimental demonstrations indicate that two indices (PI and AI) are effectively used to simultaneously quantify blood pressure and RBC aggregation.

Entities:  

Mesh:

Year:  2019        PMID: 31050348     DOI: 10.1039/c9an00025a

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  6 in total

1.  A portable rotating disc as blood rheometer.

Authors:  Rahul Agarwal; Arnab Sarkar; Subhechchha Paul; Suman Chakraborty
Journal:  Biomicrofluidics       Date:  2019-12-02       Impact factor: 2.800

2.  Ultrasound Standing Wave-Based Cell-to-liquid Separation for Measuring Viscosity and Aggregation of Blood Sample.

Authors:  Gwangho Kim; Sanghwa Jeong; Yang Jun Kang
Journal:  Sensors (Basel)       Date:  2020-04-17       Impact factor: 3.576

3.  Microfluidic-Based Biosensor for Sequential Measurement of Blood Pressure and RBC Aggregation Over Continuously Varying Blood Flows.

Authors:  Yang Jun Kang
Journal:  Micromachines (Basel)       Date:  2019-08-30       Impact factor: 2.891

4.  Experimental Investigation of Air Compliance Effect on Measurement of Mechanical Properties of Blood Sample Flowing in Microfluidic Channels.

Authors:  Yang Jun Kang
Journal:  Micromachines (Basel)       Date:  2020-04-28       Impact factor: 2.891

5.  Design, preparation, and characterization of CS/PVA/SA hydrogels modified with mesoporous Ag2O/SiO2 and curcumin nanoparticles for green, biocompatible, and antibacterial biopolymer film.

Authors:  Ashkan Farazin; Mehdi Mohammadimehr; Amir Hossein Ghasemi; Hossein Naeimi
Journal:  RSC Adv       Date:  2021-10-06       Impact factor: 4.036

6.  Microfluidic-Based Biosensor for Blood Viscosity and Erythrocyte Sedimentation Rate Using Disposable Fluid Delivery System.

Authors:  Yang Jun Kang
Journal:  Micromachines (Basel)       Date:  2020-02-20       Impact factor: 2.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.